151 related articles for article (PubMed ID: 7918131)
21. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
[TBL] [Abstract][Full Text] [Related]
22. Acadesine (AICA-riboside) improves postischemic cardiac recovery.
Bolling SF; Groh MA; Mattson AM; Grinage RA; Gallagher KP
Ann Thorac Surg; 1992 Jul; 54(1):93-8. PubMed ID: 1610261
[TBL] [Abstract][Full Text] [Related]
23. Acadesine increases blood flow in the collateralized heart during exercise.
Ishibashi Y; Quebbeman BB; Duncker DJ; Klassen C; Bache RJ
J Cardiovasc Pharmacol; 1998 Oct; 32(4):552-61. PubMed ID: 9781923
[TBL] [Abstract][Full Text] [Related]
24. Role of acadesine in clinical myocardial protection.
Alkhulaifi AM; Pugsley WB
Br Heart J; 1995 Apr; 73(4):304-5. PubMed ID: 7756061
[No Abstract] [Full Text] [Related]
25. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
Kuhn A; Carlsson J; Miketic S; Tebbe U
Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
[TBL] [Abstract][Full Text] [Related]
26. Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: a double-blind, placebo controlled crossover stress echocardiographic study.
Tommasi S; Carluccio E; Bentivoglio M; Corea L; Picano E
J Am Coll Cardiol; 2000 Jan; 35(1):83-8. PubMed ID: 10636264
[TBL] [Abstract][Full Text] [Related]
27. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography.
Mahmarian JJ; Fenimore NL; Marks GF; Francis MJ; Morales-Ballejo H; Verani MS; Pratt CM
J Am Coll Cardiol; 1994 Jul; 24(1):25-32. PubMed ID: 8006274
[TBL] [Abstract][Full Text] [Related]
28. Randomized double-blind study of pindolol in patients with stable angina pectoris.
Harston WE; Friesinger GC
Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
[TBL] [Abstract][Full Text] [Related]
29. Acadesine, an adenosine-regulating agent with the potential for widespread indications.
Drew BG; Kingwell BA
Expert Opin Pharmacother; 2008 Aug; 9(12):2137-44. PubMed ID: 18671468
[TBL] [Abstract][Full Text] [Related]
30. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
[TBL] [Abstract][Full Text] [Related]
31. Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.
Mullane K
Cardiovasc Res; 1993 Jan; 27(1):43-7. PubMed ID: 8458030
[TBL] [Abstract][Full Text] [Related]
32. Effects of the repeated administration of adenosine and heparin on myocardial perfusion in patients with chronic stable angina pectoris.
Barron HV; Sciammarella MG; Lenihan K; Michaels AD; Botvinick EH
Am J Cardiol; 2000 Jan; 85(1):1-7. PubMed ID: 11078227
[TBL] [Abstract][Full Text] [Related]
33. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
34. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
[TBL] [Abstract][Full Text] [Related]
35. Does placebo improve indexes of effort-induced myocardial ischemia? An objective study in 150 patients with chronic stable angina pectoris.
Khurmi NS; Bowles MJ; Kohli RS; Raftery EB
Am J Cardiol; 1986 Apr; 57(11):907-11. PubMed ID: 3515895
[TBL] [Abstract][Full Text] [Related]
36. Exercise tolerance in angina is improved by mivazerol--an alpha 2-adrenoceptor agonist.
Wright RA; Decroly P; Kharkevitch T; Oliver MF
Cardiovasc Drugs Ther; 1993 Dec; 7(6):929-34. PubMed ID: 7912103
[TBL] [Abstract][Full Text] [Related]
37. Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris.
Tsuya T; Okada M; Horie H; Ishikawa K
Am J Cardiol; 1990 Aug; 66(3):275-8. PubMed ID: 2195863
[TBL] [Abstract][Full Text] [Related]
38. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina.
Chen JW; Lee WL; Hsu NW; Lin SJ; Ting CT; Wang SP; Chang MS
Am J Cardiol; 1997 Jul; 80(1):32-8. PubMed ID: 9205016
[TBL] [Abstract][Full Text] [Related]
39. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
Grönefeld G; Bernhardt J; Schneider W
Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
[TBL] [Abstract][Full Text] [Related]
40. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
